BMJ · 1982 · 90 citations · 10 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsBlood Pressure ControlBlood Pressure ManagementBlood Pressure RegulationHypertension ManagementHypertension PharmacotherapyRenal HemodynamicsAntihypertensive Drug TherapyAntihypertensive PharmacologyBlood PressureBlood Pressure PharmacodynamicsHypertensive Renal HemodynamicsPulmonary Capillary Wedge PressureRenal Vascular ResistanceSupine Hypertension
The new selective 5-HT2 receptor blocking agent ketanserin was given in a dose of 10 mg intravenously to 12 patients with essential hypertension. It caused a distinct fall in supine systemic arterial, right atrial, pulmonary artery, and pulmonary capillary "wedge" pressures. Cardiac output, renal blood flow, and glomerular filtration rate showed no persistent changes. Thus 5-HT2 receptor blockade caused dilatation of both resistance and capacitance vessels and of the renal vascular bed. Heart rate and plasma concentrations of renin and noradrenaline rose after ketanserin. These data suggest that 5-HT may have a role in maintaining high blood pressure.
10
Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
J.E. Leysen, F. Awouters, Ludo Kennis et al. · Life Sciences · 1981 · 846 citations
A sensitive radioenzymatic assay for norepinephrine in tissues and plasma
David P. Henry, Barbra J. Starman, David G. Johnson et al. · Life Sciences · 1975 · 475 citations